journal article Dec 09, 2025

Testing the Possibility of Preventing Systemic Lupus Erythematosus

Arthritis & Rheumatology Vol. 78 No. 4 pp. 785-787 · Wiley
View at Publisher Save 10.1002/art.43444
Topics

No keywords indexed for this article. Browse by subject →

References
16
[1]
Kapsala NN "From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study" Clin Exp Rheumatol (2023)
[2]
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen et al.

Annals of the Rheumatic Diseases 10.1136/ard-2023-224762
[8]
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón et al.

Arthritis & Rheumatism 10.1002/art.34473
[9]
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

Nathalie Costedoat-Chalumeau, Zahir Amoura, Jean-Sébastien Hulot et al.

Annals of the Rheumatic Diseases 10.1136/ard.2006.067835
[10]
A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis

Kevin D. Deane, Christopher C. Striebich, Marie L. Feser et al.

Arthritis & Rheumatology 10.1002/art.43366
Metrics
0
Citations
16
References
Details
Published
Dec 09, 2025
Vol/Issue
78(4)
Pages
785-787
License
View
Cite This Article
Karen H. Costenbader, Zahi Touma, Marta Mosca (2025). Testing the Possibility of Preventing Systemic Lupus Erythematosus. Arthritis & Rheumatology, 78(4), 785-787. https://doi.org/10.1002/art.43444